Elon Musk Pledges Round-the-Clock Work After X Outage

Published 16 hours agoTSLA

Elon Musk Pledges Round-the-Clock Work After X Outage

Elon Musk's social media platform, X, encountered a major disruption on Saturday, May 24, 2025, with the outage impacting over 25,800 users at its height. This incident primarily affected users in the United States, but several other countries were also influenced, as reported by Reuters.

In reaction to this outage, Musk took to X to announce his return to a '24/7' work schedule. He is redirecting his efforts toward not only restoring X but also advancing his other ventures including xAI, Tesla, and the anticipated Starship launch. He underlined the critical importance of these technologies in his commitment.

Previously this year, in March 2025, Musk attributed various issues with X to a 'massive cyberattack.' This event was characterized as being orchestrated by either an expansive, coordinated group or possibly a nation-state, according to the San Francisco Chronicle. Musk’s redoubled dedication comes amidst scrutiny from investors over his political involvement and its connection to reduced Tesla sales. In response, he has assured a decrease in political activities to focus more on his businesses, as covered by Reuters.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Pfizer Makes Major Moves with 3SBio Deal and Dividend Increase

Pfizer Makes Major Moves with 3SBio Deal and Dividend Increase

55 minutes agoPFE

Pfizer has reached a major licensing agreement with Chinese biotech company 3SBio for a promising bispecific cancer drug, SSGJ-707. The deal involves a $1.25 billion upfront payment and potential milestones worth up to $4.8 billion. In addition, Pfizer plans to invest $100 million in 3SBio, gaining rights to the drug outside China, with Phase III trials set to kick off in China later this year, according to Axios. In another key development, Pfizer announced an increase in its quarterly cash dividend to $0.43 per share for the first quarter of 2025. This will mark its 345th consecutive quarterly dividend, reinforcing the company's robust financial health and its ongoing dedication to delivering shareholder value, as stated in a company press release. Furthermore, Pfizer is pushing forward with a new cost-cutting initiative aimed at trimming approximately $1.5 billion from its expenses by 2027. This plan includes changes to operational processes, network structures, and product lines. Alongside these financial strategies, Pfizer continues to focus on oncology research, highlighting more than 60 presentations at the upcoming ASCO Annual Meeting, showcasing its significant progress in cancer treatment research.

Paramount Global Rises While Interpublic Group Struggles

Paramount Global Rises While Interpublic Group Struggles

1 hours agoPARA

Paramount Global has recently emerged as a star in the communication services sector, with its shares jumping 14.1% to $34.94 in a recent trading session. This rise places Paramount among the top gainers in the market, spotlighting its recent successes and strategic advancements. According to data from GuruFocus, Paramount Global's first quarter of 2025 earnings report showed total revenue of $7.2 billion, a 2% year-over-year increase when excluding the Super Bowl. The company reported adjusted OIBDA of $688 million and free cash flow of $123 million. Notably, Paramount+ subscribers reached 79 million globally, reflecting an 11% increase, and revenue for the service rose by 16%. Additionally, Pluto TV's viewing time grew by 26% year-over-year. In efforts to bolster its measurement capabilities, Paramount finalized a multi-year agreement with Nielsen for enhanced audience analytics. On the other hand, Interpublic Group has been labeled a top decliner in the sector. While detailed performance specifics haven't been disclosed, it suggests underlying challenges that differ from Paramount's upward trajectory. As Paramount thrives, the contrast highlights the varied dynamics within the communication services industry.

UnitedHealth Faces Multiple Challenges Amid Leadership Changes

UnitedHealth Faces Multiple Challenges Amid Leadership Changes

UnitedHealth Group has recently been in the spotlight due to several controversies and strategic shifts. The company faced allegations, reported by The Guardian, of secretly paying nursing homes to reduce hospital transfers, a claim UnitedHealth denied, citing a U.S. Department of Justice finding that the charges were inaccurate. Nevertheless, the report negatively impacted UnitedHealth's stock price, which is currently at $295.57, reflecting a slight decrease from previous levels. In a sudden change of leadership, CEO Andrew Witty has stepped down, citing personal reasons, during a period of rising medical costs and declining share value. Stephen Hemsley, who formerly led the company from 2006 to 2017, has returned as CEO. He has been granted a $1 million annual salary and a $60 million equity award as part of his compensation package. Additionally, UnitedHealth has increased its security expenditures significantly, spending nearly $1.7 million in 2024 following the tragic shooting of former CEO Brian Thompson. Legal challenges add to UnitedHealth's current landscape, including a lawsuit from investors over withheld information following Thompson's death and an ongoing Department of Justice fraud investigation into UnitedHealth's Medicare Advantage billing practices. Additionally, the company revised its 2025 financial outlook, expecting adjusted earnings of $26 to $26.50 per share due to unexpected rises in medical care usage. These developments reflect the heightened scrutiny and instability the healthcare giant is facing.

BofA Ups AutoZone Price Target Amid Growth Expectations

BofA Ups AutoZone Price Target Amid Growth Expectations

Bank of America has recently revised its price target for AutoZone, elevating it to $3,700 from the previous $3,600, while maintaining a 'Neutral' rating on the stock. The update comes as the company demonstrates steady growth through its commercial programs and expansion of its hubs, though it faces challenges such as a lackluster retail DIY sector and a generally subdued industry growth outlook. BofA's new price target is based on applying a 20x multiple to the projected fiscal year 2026 earnings per share. This valuation aligns with the broader trend of multiple expansion within the peer group. AutoZone's current stock performance supports this outlook, trading near its 52-week high of $3,256.37 and holding a market capitalization of $54.91 billion, according to Investing.com. While AutoZone's commercial strategy and infrastructure investments show promise, these factors should be balanced with broader market analyses and other analyst opinions before investments are made. The company continues to navigate industry pressures, yet it remains a significant player in its sector.